Oxygen Biotherapeutics Announces Closing of Its Previously Announced Private Placement of Unregistered Convertible Notes and Warrants
Oxygen Biotherapeutics, Inc. (Nasdaq: OXBT) today announced that it closed its previously announced private placement of unregistered convertible notes and unregistered warrants. The final amount of transaction was $4.9 million, an increase from the previously reported $4.6 million, as a result of an additional $0.3 million in Notes and Warrants that were offered and sold to an additional institutional investor. The transaction resulted in gross proceeds of $4.9 million to Oxygen, excluding any proceeds from exercise of the Warrants, and aggregate placement agent fees of approximately $297,000.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.